首页 > 最新文献

Hepato-gastroenterology最新文献

英文 中文
Association between chronic use of proton pump inhibitors and small- intestinal bacterial overgrowth assessed using lactulose hydrogen breath tests. 使用乳果糖氢呼吸试验评估长期使用质子泵抑制剂与小肠细菌过度生长之间的关系。
Pub Date : 2015-03-01
Yasuhiro Fujiwara, Toshio Watanabe, Motoko Muraki, Hirokazu Yamagami, Tetsuya Tanigawa, Masatsugu Shiba, Kazunari Tominaga, Tetsuo Arakawa

Background/aims: Several adverse events have been reported in patients who are chronic users of proton pump inhibitors (PPIs); however, the association between PPI use and small-intestinal bacterial overgrowth (SIBO) is controversial. We examined the prevalence of SIBO, as assessed by the lactulose hydrogen breath test (LHBT), based on the use of gastric acid-suppressive drugs in Japanese patients. METH- ODOLOGY: Ninety-four patients who were examined by the LHBT were assessed retrospectively. We used several criteria to define a positive LHBT result. Nine patients received probiotics containing Lactobacillus casei.

Results: Fifty patients were PPI users, 14 were histamine-2 receptor antagonist (H2RA) users, and were 30 non-PPI and non-H2RA users (controls). There were no significant differences in prevalence of LHBT-positive cases among the three groups. Multiple-adjusted regression showed no significant association between PPI use and being LHBT-positive. Prevalence of postprandial fullness in PPI users was high (46%), but such symptoms were not related to LHBT results. Four (44%) of 9 cases became LHBT-negative and the maximal peak of H2 production decreased significantly after probiotic treatment.

Conclusions: PPI treatment is not associated with SIBO in Japanese patients. Mechanisms apart from SIBO could cause the high prevalence of postprandial fullness in PPI users.

背景/目的:在长期使用质子泵抑制剂(PPIs)的患者中已经报道了一些不良事件;然而,PPI的使用与小肠细菌过度生长(SIBO)之间的关系是有争议的。我们通过乳果糖氢呼气试验(LHBT)评估了SIBO的患病率,基于日本患者使用胃酸抑制药物。方法:对94例经LHBT检查的患者进行回顾性评估。我们使用了几个标准来定义LHBT阳性结果。9名患者接受了含有干酪乳杆菌的益生菌治疗。结果:50例患者为PPI使用者,14例为组胺-2受体拮抗剂(H2RA)使用者,30例为非PPI和非H2RA使用者(对照组)。三组间lhbt阳性病例的患病率无显著差异。多重调整回归显示PPI使用与lhbt阳性无显著相关性。PPI使用者的餐后饱腹感发生率很高(46%),但这些症状与LHBT结果无关。9例中有4例(44%)变为lhbt阴性,经益生菌处理后H2产峰显著降低。结论:PPI治疗与日本患者SIBO无关。SIBO以外的机制可能导致PPI使用者餐后饱腹感的高发。
{"title":"Association between chronic use of proton pump inhibitors and small- intestinal bacterial overgrowth assessed using lactulose hydrogen breath tests.","authors":"Yasuhiro Fujiwara,&nbsp;Toshio Watanabe,&nbsp;Motoko Muraki,&nbsp;Hirokazu Yamagami,&nbsp;Tetsuya Tanigawa,&nbsp;Masatsugu Shiba,&nbsp;Kazunari Tominaga,&nbsp;Tetsuo Arakawa","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>Several adverse events have been reported in patients who are chronic users of proton pump inhibitors (PPIs); however, the association between PPI use and small-intestinal bacterial overgrowth (SIBO) is controversial. We examined the prevalence of SIBO, as assessed by the lactulose hydrogen breath test (LHBT), based on the use of gastric acid-suppressive drugs in Japanese patients. METH- ODOLOGY: Ninety-four patients who were examined by the LHBT were assessed retrospectively. We used several criteria to define a positive LHBT result. Nine patients received probiotics containing Lactobacillus casei.</p><p><strong>Results: </strong>Fifty patients were PPI users, 14 were histamine-2 receptor antagonist (H2RA) users, and were 30 non-PPI and non-H2RA users (controls). There were no significant differences in prevalence of LHBT-positive cases among the three groups. Multiple-adjusted regression showed no significant association between PPI use and being LHBT-positive. Prevalence of postprandial fullness in PPI users was high (46%), but such symptoms were not related to LHBT results. Four (44%) of 9 cases became LHBT-negative and the maximal peak of H2 production decreased significantly after probiotic treatment.</p><p><strong>Conclusions: </strong>PPI treatment is not associated with SIBO in Japanese patients. Mechanisms apart from SIBO could cause the high prevalence of postprandial fullness in PPI users.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 138","pages":"268-72"},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33253467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interferon α2b increases MMP-13 and IL-10 expression in Kupffer cells through MAPK signaling pathways. 干扰素α2b通过MAPK信号通路增加Kupffer细胞中MMP-13和IL-10的表达。
Pub Date : 2015-03-01
Zheng Yu, Man Xie, Xu Fan, Jidong Jia

Background/aims: Kupffer cells play critical roles in both progression and resolution of liver fibrosis. Interferon α2b is an important immunoregulator which has anti-fibrotic effect in addition to its antiviral effect. It remained unclear whether the anti-fibrotic effect of interferon α2b is mediated by regulating functions of Kupffer cells.

Methodology: Primary isolated Kupffer cells were cultured with interferon α2b and the expression of matrix metalloproteinase-13, interleukin-10, transforming growth factor -β1 and tumor necrosis factor-α were measured. To investigate the role of mitogen-activated protein kinase pathways in regulating cytokines production by interferon α2b-stimulated Kupffer cells, inhibitors were given before cells were treated with interferon a2b.

Results: Cell purity was more than 98%. Stimulating Kupffer cells with interferon α2b led to a dramatic increase in matrix metalloproteinase-13 and interleukin-10 expression. In contrast, the values of tumor necrosis factor-α and transforming growth factor -β1 remained unchanged throughout the 24-hour observation period. Inhibited ERK1/2 pathway prevented interferon α2b-triggered matrix metalloproteinase-13 production, while inhibited p38MAPK, ERK1/2 or JNK signaling pathways all blocked interleukin-10 expression.

Conclusions: Interferon α2b may exert anti-fibrotic effect by elevating the level of matrix metalloproteinase-13 and interleukin-10 in Kupffer cells, in a mitogen-activated protein kinase signaling pathways-dependent manner.

背景/目的:库普弗细胞在肝纤维化的进展和消退中起关键作用。干扰素α2b是一种重要的免疫调节剂,除具有抗病毒作用外,还具有抗纤维化作用。干扰素α2b的抗纤维化作用是否通过调节Kupffer细胞的功能介导尚不清楚。方法:用干扰素α2b培养原代离体Kupffer细胞,检测基质金属蛋白酶-13、白细胞介素-10、转化生长因子-β1、肿瘤坏死因子-α的表达。为了研究丝裂原激活的蛋白激酶途径在干扰素α2b刺激的Kupffer细胞产生细胞因子中的作用,在干扰素a2b处理细胞之前给予抑制剂。结果:细胞纯度大于98%。干扰素α2b刺激Kupffer细胞可显著增加基质金属蛋白酶-13和白细胞介素-10的表达。而肿瘤坏死因子-α和转化生长因子-β1在24小时的观察期内没有变化。抑制ERK1/2通路可阻止干扰素α2b触发的基质金属蛋白酶-13的产生,而抑制p38MAPK、ERK1/2或JNK信号通路均可阻断白细胞介素-10的表达。结论:干扰素α2b可能通过上调Kupffer细胞中基质金属蛋白酶-13和白细胞介素-10的水平发挥抗纤维化作用,其机制依赖于丝裂原激活的蛋白激酶信号通路。
{"title":"Interferon α2b increases MMP-13 and IL-10 expression in Kupffer cells through MAPK signaling pathways.","authors":"Zheng Yu,&nbsp;Man Xie,&nbsp;Xu Fan,&nbsp;Jidong Jia","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>Kupffer cells play critical roles in both progression and resolution of liver fibrosis. Interferon α2b is an important immunoregulator which has anti-fibrotic effect in addition to its antiviral effect. It remained unclear whether the anti-fibrotic effect of interferon α2b is mediated by regulating functions of Kupffer cells.</p><p><strong>Methodology: </strong>Primary isolated Kupffer cells were cultured with interferon α2b and the expression of matrix metalloproteinase-13, interleukin-10, transforming growth factor -β1 and tumor necrosis factor-α were measured. To investigate the role of mitogen-activated protein kinase pathways in regulating cytokines production by interferon α2b-stimulated Kupffer cells, inhibitors were given before cells were treated with interferon a2b.</p><p><strong>Results: </strong>Cell purity was more than 98%. Stimulating Kupffer cells with interferon α2b led to a dramatic increase in matrix metalloproteinase-13 and interleukin-10 expression. In contrast, the values of tumor necrosis factor-α and transforming growth factor -β1 remained unchanged throughout the 24-hour observation period. Inhibited ERK1/2 pathway prevented interferon α2b-triggered matrix metalloproteinase-13 production, while inhibited p38MAPK, ERK1/2 or JNK signaling pathways all blocked interleukin-10 expression.</p><p><strong>Conclusions: </strong>Interferon α2b may exert anti-fibrotic effect by elevating the level of matrix metalloproteinase-13 and interleukin-10 in Kupffer cells, in a mitogen-activated protein kinase signaling pathways-dependent manner.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 138","pages":"350-4"},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33195080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-incision laparoscopic distal gastrectomy for early gastric cancer through a homemade single port access device. 自制单孔通道装置单切口腹腔镜早期胃癌远端切除术。
Pub Date : 2015-03-01
Zhi-Wei Jiang, Shu Zhang, Gang Wang, Kun Zhao, Jiang Liu, Li Ning, Jieshou Li

Background/aims: We presented a series of single-incision laparoscopic distal gastrectomies for early gastric cancer patients through a type of homemade single port access device and some other conventional laparoscopic instruments.

Methodology: A single-incision laparoscopic distal gastrectomy with D1 + α lymph node dissection was performed on a 46 years old male patient who had an early gastric cancer.

Results: This single port access device has facilitated the conventional laparoscopic instruments to accomplish the surgery and we made in only 6 minutes. Total operating time for this surgery was 240 minutes. During the operation, there were about 100 milliliters of blood loss, and 17 lymph-nodes were retrieved.

Conclusion: This homemade single port access device shows its superiority in economy and convenience for complex single-incision surgeries. Single-incision laparoscopic distal gastrectomy for early gastric cancer can be conducted by experienced laparoscopic surgeons. Fully take advantage of both SILS and fast track surgery plan can bring to successful surgeries with minimal postoperative pain, quicker mobilization, early recovery of intestinal function, and better cosmesis effect for the patients.

背景/目的:我们采用自制的单孔通道装置和一些常规的腹腔镜器械,对早期胃癌患者进行一系列的单切口腹腔镜远端胃切除术。方法:对46岁男性早期胃癌患者行单切口腹腔镜远端胃切除术并D1 + α淋巴结清扫术。结果:该单通道装置方便了常规腹腔镜器械完成手术,手术时间仅为6分钟。手术总时间为240分钟。术中出血量约100毫升,切除淋巴结17个。结论:自制的单口接入器在复杂的单切口手术中具有经济、方便的优势。早期胃癌单切口腹腔镜远端胃切除术可由经验丰富的腹腔镜外科医生进行。充分利用SILS和快速通道手术方案的优势,可以使手术成功,术后疼痛最小,活动更快,肠道功能恢复早,患者美容效果好。
{"title":"Single-incision laparoscopic distal gastrectomy for early gastric cancer through a homemade single port access device.","authors":"Zhi-Wei Jiang,&nbsp;Shu Zhang,&nbsp;Gang Wang,&nbsp;Kun Zhao,&nbsp;Jiang Liu,&nbsp;Li Ning,&nbsp;Jieshou Li","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>We presented a series of single-incision laparoscopic distal gastrectomies for early gastric cancer patients through a type of homemade single port access device and some other conventional laparoscopic instruments.</p><p><strong>Methodology: </strong>A single-incision laparoscopic distal gastrectomy with D1 + α lymph node dissection was performed on a 46 years old male patient who had an early gastric cancer.</p><p><strong>Results: </strong>This single port access device has facilitated the conventional laparoscopic instruments to accomplish the surgery and we made in only 6 minutes. Total operating time for this surgery was 240 minutes. During the operation, there were about 100 milliliters of blood loss, and 17 lymph-nodes were retrieved.</p><p><strong>Conclusion: </strong>This homemade single port access device shows its superiority in economy and convenience for complex single-incision surgeries. Single-incision laparoscopic distal gastrectomy for early gastric cancer can be conducted by experienced laparoscopic surgeons. Fully take advantage of both SILS and fast track surgery plan can bring to successful surgeries with minimal postoperative pain, quicker mobilization, early recovery of intestinal function, and better cosmesis effect for the patients.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 138","pages":"518-23"},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33253612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk, diagnosis and treatment to postoperative delirium in elderly patients with gastrointestinal cancers. 老年胃肠道肿瘤患者术后谵妄的危险、诊断和治疗。
Pub Date : 2015-03-01
Li-Na Ma, Rui-Li Zhang

In recent years, more elderly patients with gastrointestinal cancers have been undergoing surgery. As one of main postoperative complications, postoperative delirium (POD) is harmful and difficult to prevent and treat. Prevention, diagnosis and treatment to POD properly and ptomptly can promote the patient's overall recovery. However, health care providers still have many problems for POD to face in elderly,with gastrointestinal cancers during the clinical care. In this paper, Etiology, damages, prevention, diagnosis and treatment of POD in elderly with gastrointestinal cancer were reviewed, and the prospect of POD was also discussed.

近年来,越来越多的老年胃肠癌患者接受手术治疗。术后谵妄是术后主要并发症之一,危害大,防治难度大。正确、及时地对POD进行预防、诊断和治疗,可以促进患者的全面康复。然而,对于患有胃肠癌的老年POD患者,在临床护理中仍存在许多问题。本文就老年胃肠癌患者POD的病因、损害、预防、诊断和治疗进行综述,并对其发展前景进行展望。
{"title":"Risk, diagnosis and treatment to postoperative delirium in elderly patients with gastrointestinal cancers.","authors":"Li-Na Ma,&nbsp;Rui-Li Zhang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In recent years, more elderly patients with gastrointestinal cancers have been undergoing surgery. As one of main postoperative complications, postoperative delirium (POD) is harmful and difficult to prevent and treat. Prevention, diagnosis and treatment to POD properly and ptomptly can promote the patient's overall recovery. However, health care providers still have many problems for POD to face in elderly,with gastrointestinal cancers during the clinical care. In this paper, Etiology, damages, prevention, diagnosis and treatment of POD in elderly with gastrointestinal cancer were reviewed, and the prospect of POD was also discussed.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 138","pages":"529-35"},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33253613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Individualized perfusion of sargent gloryvine decoction for clinical severe acute pancreatitis treatment. 格洛藤汤个体化灌注治疗临床重症急性胰腺炎。
Pub Date : 2015-03-01
Ni Jun, Yuan Wenbin, Cen Feng, Yan Qiang, Zhang Guolei

Background/aims: To observe the effects of Sargent gloryvine decoction (SGD) on severe acute pancreatitis (SAP) treatment and to evaluate its clinical value.

Methodology: 112 patients of SAP in our hospital from January, 2005 to December, 2012 were recruited for retrospective analysis. They were divided into two groups, SGD group (62 patients) and control group without treated with SGD (50 patients). Inflammation factor, CT grade and Ranson grade were used to estimate the severity of SAP, and were compared in these two groups. In addition, peripancreatic infection, incidence of pseudo pancreatic cyst, time of anal exsufflation and duration of fever were used to evaluate the effect of SGD treatment. After perfusion of SGD for different time, hospitalization days and cost were recorded to evaluate clinical value of SGD.

Results: After perfusion, many indexes in SGD were remarkably superior to those of control group, such as duration of fever, incidence of pseudo pancreatic cyst, peripancreatic infection and Ranson grade. Meanwhile, SGD can sharply down-regulate inflammation reaction levels of SAP patients, so that the hospitalization days and costs can be obviously saved.

Conclusion: According to comparison, perfusion of SGD is a potential candidate for SAP treatment and is valuable in clinical application.

背景/目的:观察金缕藤汤(SGD)治疗重症急性胰腺炎(SAP)的疗效并评价其临床价值。方法:选取我院2005年1月至2012年12月收治的112例SAP患者进行回顾性分析。将患者分为SGD组(62例)和未使用SGD的对照组(50例)。采用炎症因子、CT分级和Ranson分级评估SAP的严重程度,并对两组患者进行比较。并以胰周感染、假性胰腺囊肿发生率、肛门排气时间、发热持续时间评价SGD治疗效果。记录SGD灌注不同时间后的住院天数和费用,评价SGD的临床价值。结果:灌注后,SGD患者发热时间、假性胰腺囊肿发生率、胰腺周围感染、Ranson分级等多项指标均明显优于对照组。同时,SGD能显著降低SAP患者的炎症反应水平,从而明显节省住院天数和费用。结论:经比较,SGD灌注治疗SAP是一种潜在的治疗方案,具有临床应用价值。
{"title":"Individualized perfusion of sargent gloryvine decoction for clinical severe acute pancreatitis treatment.","authors":"Ni Jun,&nbsp;Yuan Wenbin,&nbsp;Cen Feng,&nbsp;Yan Qiang,&nbsp;Zhang Guolei","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>To observe the effects of Sargent gloryvine decoction (SGD) on severe acute pancreatitis (SAP) treatment and to evaluate its clinical value.</p><p><strong>Methodology: </strong>112 patients of SAP in our hospital from January, 2005 to December, 2012 were recruited for retrospective analysis. They were divided into two groups, SGD group (62 patients) and control group without treated with SGD (50 patients). Inflammation factor, CT grade and Ranson grade were used to estimate the severity of SAP, and were compared in these two groups. In addition, peripancreatic infection, incidence of pseudo pancreatic cyst, time of anal exsufflation and duration of fever were used to evaluate the effect of SGD treatment. After perfusion of SGD for different time, hospitalization days and cost were recorded to evaluate clinical value of SGD.</p><p><strong>Results: </strong>After perfusion, many indexes in SGD were remarkably superior to those of control group, such as duration of fever, incidence of pseudo pancreatic cyst, peripancreatic infection and Ranson grade. Meanwhile, SGD can sharply down-regulate inflammation reaction levels of SAP patients, so that the hospitalization days and costs can be obviously saved.</p><p><strong>Conclusion: </strong>According to comparison, perfusion of SGD is a potential candidate for SAP treatment and is valuable in clinical application.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 138","pages":"459-62"},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33254686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical prognostic index for survival in patients with unresectable pancreatic cancer treated with gemcitabine or S-1. 吉西他滨或S-1治疗不可切除胰腺癌患者生存的实用预后指数。
Pub Date : 2015-03-01
Tatsuya Kurihara, Mari Kogo, Masakazu Ishii, Keiichiro Yoneyama, Katsuya Kitamura, Ken Shimada, Shunichi Shimizu, Hitoshi Yoshida, Yuji Kiuchi

Background/aims: We performed this retrospective cohort study to identify prognostic factors for unresectable pancreatic cancer treated with current standard therapy using gemcitabine (GEM) or S-1 and to stratify patients prior to treatment using a prognostic index (PI).

Methodology: We analyzed 182 patients with unresectable pancreatic cancer, who had received GEM or S-1 as first-line chemotherapy. Factors that contributed to the prognosis were identified by univariate and multivariate analysis using a Cox proportional hazards model. The PI was constructed using the factors identified in the multivariate analysis.

Results: By multivariate analysis, performance status (PS), stage, and absolute neutrophil count (ANC) were identified as factors that independently contributed to the prognosis of unresectable pancreatic cancer (P < 0.05). The hazard ratios were 1.69, 3.33, and 1.18, respectively. In addition, PI was calculated using these three factors. Patients were classified into three groups according to the PI values. A significant difference was observed among the survival curves of these three groups (P < 0.05).

Conclusions: We identified three prognostic factors in the population after the introduction of S-1, and have created a simple and useful PI. This index demonstrates the ability to accurately classify advanced pancreatic cancer patients before the start of treatment.

背景/目的:我们进行了这项回顾性队列研究,以确定目前使用吉西他滨(GEM)或S-1标准治疗的不可切除胰腺癌的预后因素,并在治疗前使用预后指数(PI)对患者进行分层。方法:我们分析了182例不能切除的胰腺癌患者,他们接受了GEM或S-1作为一线化疗。采用Cox比例风险模型,通过单因素和多因素分析确定影响预后的因素。使用多变量分析中确定的因素构建PI。结果:通过多因素分析,性能状态(performance status, PS)、分期、绝对中性粒细胞计数(absolute neutropil count, ANC)是影响不可切除胰腺癌预后的独立因素(P < 0.05)。风险比分别为1.69、3.33和1.18。此外,利用这三个因素计算PI。根据PI值将患者分为三组。三组患者的生存曲线比较差异有统计学意义(P < 0.05)。结论:我们在引入S-1后确定了人群中的三个预后因素,并创建了一个简单而有用的PI。该指标显示了在治疗开始前对晚期胰腺癌患者进行准确分类的能力。
{"title":"Practical prognostic index for survival in patients with unresectable pancreatic cancer treated with gemcitabine or S-1.","authors":"Tatsuya Kurihara,&nbsp;Mari Kogo,&nbsp;Masakazu Ishii,&nbsp;Keiichiro Yoneyama,&nbsp;Katsuya Kitamura,&nbsp;Ken Shimada,&nbsp;Shunichi Shimizu,&nbsp;Hitoshi Yoshida,&nbsp;Yuji Kiuchi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>We performed this retrospective cohort study to identify prognostic factors for unresectable pancreatic cancer treated with current standard therapy using gemcitabine (GEM) or S-1 and to stratify patients prior to treatment using a prognostic index (PI).</p><p><strong>Methodology: </strong>We analyzed 182 patients with unresectable pancreatic cancer, who had received GEM or S-1 as first-line chemotherapy. Factors that contributed to the prognosis were identified by univariate and multivariate analysis using a Cox proportional hazards model. The PI was constructed using the factors identified in the multivariate analysis.</p><p><strong>Results: </strong>By multivariate analysis, performance status (PS), stage, and absolute neutrophil count (ANC) were identified as factors that independently contributed to the prognosis of unresectable pancreatic cancer (P < 0.05). The hazard ratios were 1.69, 3.33, and 1.18, respectively. In addition, PI was calculated using these three factors. Patients were classified into three groups according to the PI values. A significant difference was observed among the survival curves of these three groups (P < 0.05).</p><p><strong>Conclusions: </strong>We identified three prognostic factors in the population after the introduction of S-1, and have created a simple and useful PI. This index demonstrates the ability to accurately classify advanced pancreatic cancer patients before the start of treatment.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 138","pages":"478-84"},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33254690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison between anatomical subsegmentectomy and nonanatomical partial resection for hepatocellular carcinoma located within a single subsegment: a single-center retrospective analysis. 单中心回顾性分析:解剖亚节段切除术与非解剖部分切除治疗单个亚节段内肝癌的比较
Pub Date : 2015-03-01
Takehito Yamamoto, Shintaro Yagi, Ryosuke Kita, Hideyuki Masui, Hiromitsu Kinoshita, Yusuke Sakamoto, Kazuyuki Okada, Akira Miki, Masato Kondo, Hiroki Hashida, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaihara, Ryo Hosotani

Background/aims: For hepatocellular carcinoma (HCC) within a single subsegment, the superiority of anatomical subsegmentectomy over non-anatomical partial resection is still controversial. In this study, we assessed the potential benefit of subsegmentectomy.

Methodology: We selected 44 patients with a single HCC lesion within one subsegment who had undergone anatomical subsegmentectomy or non-anatomical partial resection from among 173 patients who underwent hepatectomy in our hospital from August 2003 to May 2013. We compared the results following anatomical subsegmentectomy (Group A; n = 16) and non-anatomical partial resection (Group N; n = 28).

Results: One- and two-year survival rates were 92.5% and 89.3%, respectively; 1- and 2-year recurrence-free survival (RFS) rates were 88.9% and 69.1%, respectively. There was no significant difference in overall survival or RFS between the groups. However, among HBV-positive patients, RFS was significantly better for Group A than Group N (p = 0.008).

Conclusions: For HBV-positive HCC within a single subsegment, we recommend subsegmentectomy.

背景/目的:对于单个亚段内的肝细胞癌(HCC),解剖亚段切除术优于非解剖部分切除术仍存在争议。在这项研究中,我们评估了亚节段切除术的潜在益处。方法:我们从2003年8月至2013年5月在我院行肝切除术的173例患者中选择44例在一个亚段内的单个HCC病变行解剖性亚段切除术或非解剖性部分切除术的患者。我们比较解剖亚段切除术后的结果(A组;n = 16)和非解剖性部分切除(n组;N = 28)。结果:1年和2年生存率分别为92.5%和89.3%;1年和2年无复发生存率(RFS)分别为88.9%和69.1%。两组患者的总生存率和RFS无显著差异。然而,在hbv阳性患者中,A组的RFS明显优于N组(p = 0.008)。结论:对于单个亚节段内的hbv阳性HCC,我们推荐亚节段切除术。
{"title":"Comparison between anatomical subsegmentectomy and nonanatomical partial resection for hepatocellular carcinoma located within a single subsegment: a single-center retrospective analysis.","authors":"Takehito Yamamoto,&nbsp;Shintaro Yagi,&nbsp;Ryosuke Kita,&nbsp;Hideyuki Masui,&nbsp;Hiromitsu Kinoshita,&nbsp;Yusuke Sakamoto,&nbsp;Kazuyuki Okada,&nbsp;Akira Miki,&nbsp;Masato Kondo,&nbsp;Hiroki Hashida,&nbsp;Hiroyuki Kobayashi,&nbsp;Kenji Uryuhara,&nbsp;Satoshi Kaihara,&nbsp;Ryo Hosotani","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>For hepatocellular carcinoma (HCC) within a single subsegment, the superiority of anatomical subsegmentectomy over non-anatomical partial resection is still controversial. In this study, we assessed the potential benefit of subsegmentectomy.</p><p><strong>Methodology: </strong>We selected 44 patients with a single HCC lesion within one subsegment who had undergone anatomical subsegmentectomy or non-anatomical partial resection from among 173 patients who underwent hepatectomy in our hospital from August 2003 to May 2013. We compared the results following anatomical subsegmentectomy (Group A; n = 16) and non-anatomical partial resection (Group N; n = 28).</p><p><strong>Results: </strong>One- and two-year survival rates were 92.5% and 89.3%, respectively; 1- and 2-year recurrence-free survival (RFS) rates were 88.9% and 69.1%, respectively. There was no significant difference in overall survival or RFS between the groups. However, among HBV-positive patients, RFS was significantly better for Group A than Group N (p = 0.008).</p><p><strong>Conclusions: </strong>For HBV-positive HCC within a single subsegment, we recommend subsegmentectomy.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 138","pages":"363-7"},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33134075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detailed analysis of extra-pancreatic nerve plexus invasion in pancreatic body carcinoma analyzed by 50 consecutive series of distal pancreatectomy with en-bloc celiac axis resection. 对50例连续行胰远端切除术联合腹腔轴切除术胰腺体癌胰腺外神经丛浸润情况进行详细分析。
Pub Date : 2015-03-01
Takahiro Tsuchikawa, Satoshi Hirano, Toru Nakamura, Keisuke Okamura, Eiji Tamoto, Soichi Murakami, Yo Kurashima, Yuma Ebihara, Toshiaki Shichinohe

Background/aims: Advanced pancreatic body carcinoma frequently accompany extra-pancreatic nerve plexus (PL) invasion, one of the poor indicator of patient prognosis. The present study aimed to reveal the progress of the PL invasion from cancer of the pancreas body toward the root of the celiac artery (CA) and superior mesenteric artery (SMA) followed by investigation of the relevance of diagnostic accuracy.

Methodology: Resected specimens from 50 consecutive patients who underwent distal pancreatectomy with en bloc celiac axis resection (DP-CAR) were pathologically analyzed for the direction of PL invasion. Diagnostic accuracy on CT imaging were also investigated.

Results: Thirty seven of the 50 patients (74%) were positive for PL invasion around the CHA, SPA, CA and SMA. In terms of the diagnostic accuracy, positive predictive values for the PL invasion were 35%, 36%, 43% and 81% for the SPA, CHA, CA and SMA, respectively. Among 21 patients and 23 patients with PL invasion around CHA and SPA, 13 and 6 patients also accompanied PL invasion around CA, respectively.

Conclusions: Carcinoma of the pancreatic body is found to frequently accompany PL invasion around CA. Under the limitation of low diagnostic accuracy, DP-CAR might be feasible operation that increases the possibility of R0 resection.

背景/目的:晚期胰体癌常伴有胰外神经丛(PL)浸润,是判断患者预后的不良指标之一。本研究旨在揭示胰腺体癌向腹腔动脉(CA)和肠系膜上动脉(SMA)根部浸润的进展,并探讨其诊断准确性的相关性。方法:对50例连续行远端胰切除术合并腹腔轴切除术(DP-CAR)的患者的标本进行病理分析,确定其侵袭方向。CT影像的诊断准确性也进行了探讨。结果:50例患者中有37例(74%)在CHA、SPA、CA和SMA周围出现PL侵犯。在诊断准确性方面,SPA、CHA、CA和SMA对PL侵犯的阳性预测值分别为35%、36%、43%和81%。在21例患者和23例患者中,分别有13例和6例患者伴有PL侵犯CA周围。结论:胰体癌常伴癌旁浸润,在诊断准确率较低的情况下,DP-CAR可能是一种可行的手术,可增加R0切除的可能性。
{"title":"Detailed analysis of extra-pancreatic nerve plexus invasion in pancreatic body carcinoma analyzed by 50 consecutive series of distal pancreatectomy with en-bloc celiac axis resection.","authors":"Takahiro Tsuchikawa,&nbsp;Satoshi Hirano,&nbsp;Toru Nakamura,&nbsp;Keisuke Okamura,&nbsp;Eiji Tamoto,&nbsp;Soichi Murakami,&nbsp;Yo Kurashima,&nbsp;Yuma Ebihara,&nbsp;Toshiaki Shichinohe","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>Advanced pancreatic body carcinoma frequently accompany extra-pancreatic nerve plexus (PL) invasion, one of the poor indicator of patient prognosis. The present study aimed to reveal the progress of the PL invasion from cancer of the pancreas body toward the root of the celiac artery (CA) and superior mesenteric artery (SMA) followed by investigation of the relevance of diagnostic accuracy.</p><p><strong>Methodology: </strong>Resected specimens from 50 consecutive patients who underwent distal pancreatectomy with en bloc celiac axis resection (DP-CAR) were pathologically analyzed for the direction of PL invasion. Diagnostic accuracy on CT imaging were also investigated.</p><p><strong>Results: </strong>Thirty seven of the 50 patients (74%) were positive for PL invasion around the CHA, SPA, CA and SMA. In terms of the diagnostic accuracy, positive predictive values for the PL invasion were 35%, 36%, 43% and 81% for the SPA, CHA, CA and SMA, respectively. Among 21 patients and 23 patients with PL invasion around CHA and SPA, 13 and 6 patients also accompanied PL invasion around CA, respectively.</p><p><strong>Conclusions: </strong>Carcinoma of the pancreatic body is found to frequently accompany PL invasion around CA. Under the limitation of low diagnostic accuracy, DP-CAR might be feasible operation that increases the possibility of R0 resection.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 138","pages":"455-8"},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33252746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ovarian cancer liver metastases--should we apply the principle of optimal cytoreduction to the liver? A review. 卵巢癌肝转移——我们是否应该将最佳细胞减少原则应用于肝脏?复习一下。
Pub Date : 2015-03-01
Nicolae Bacalbaşa, Irinel Popescu

Advanced stage ovarian cancer is a common situation at presentation and current medical practice lacks efficient methods of prevention and early diagnosis. Primary maximal cytoreductive surgery followed by adjuvant chemotherapy is currently a generally accepted principle; most patients however undergo recurrence and common therapeutical attitude is secondary cytoreduction based approximately on the same principles as the primary one. Due to the success of liver resections in colorectal metastases and the development of liver surgery in general, different centers worldwide analyzed in the last 20 years liver resections' utility for other primaries, including ovarian tumors.

晚期卵巢癌是一种常见的临床表现,目前的医学实践缺乏有效的预防和早期诊断方法。目前普遍接受的原则是,首先进行最大限度的细胞减少手术,然后进行辅助化疗;然而,大多数患者会复发,常见的治疗态度是继发性细胞减少,其原理与原发性细胞减少的原理大致相同。由于肝切除术在结肠直肠癌转移中的成功和肝脏手术的发展,世界各地的不同中心在过去20年中分析了肝切除术在其他原发性肿瘤中的应用,包括卵巢肿瘤。
{"title":"Ovarian cancer liver metastases--should we apply the principle of optimal cytoreduction to the liver? A review.","authors":"Nicolae Bacalbaşa,&nbsp;Irinel Popescu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Advanced stage ovarian cancer is a common situation at presentation and current medical practice lacks efficient methods of prevention and early diagnosis. Primary maximal cytoreductive surgery followed by adjuvant chemotherapy is currently a generally accepted principle; most patients however undergo recurrence and common therapeutical attitude is secondary cytoreduction based approximately on the same principles as the primary one. Due to the success of liver resections in colorectal metastases and the development of liver surgery in general, different centers worldwide analyzed in the last 20 years liver resections' utility for other primaries, including ovarian tumors.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 138","pages":"355-7"},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33128567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of laparoscopic colorectal surgery in patients of previous abdominal surgery: a systemic review and meta-analysis. 腹腔镜结直肠手术对既往腹部手术患者的疗效:一项系统综述和荟萃分析。
Pub Date : 2015-03-01
Liang Wang, Haichao Yan, Jiangtao Li

Previous abdominal surgery (PAS) is an important factor for postoperative adhesion. It is considered to be the most common complication of gastrointestinal and pelvic surgery. Both an Internet based and a manual search were used to acquire relevant studies about this topic. Parameters have been compared such as, Operating time in PAS versus Non PAS, Blood loss, Perioperative blood transfusion, Conversion to open, Anastomotic leakage and overall complications. Results of this study suggest that laparoscopy is too safe and effective in the treatment of colorectal disease for patients with previous abdominal surgery as it is for those without surgical backgrounds. However sufficient large-volume study is necessary to validate the long-term outcomes in previous abdominal surgical patients.

既往腹部手术(PAS)是造成术后粘连的重要因素。它被认为是胃肠道和盆腔手术中最常见的并发症。使用基于互联网的搜索和手动搜索来获取有关该主题的相关研究。对参数进行了比较,如PAS与非PAS的手术时间、失血量、围手术期输血、转换为开放式、吻合口渗漏和总体并发症。这项研究的结果表明,对于既往接受过腹部手术的患者来说,腹腔镜在治疗结直肠疾病方面过于安全和有效,对于那些没有手术背景的患者来说也是如此。然而,需要进行足够的大容量研究来验证既往腹部手术患者的长期结果。
{"title":"Outcomes of laparoscopic colorectal surgery in patients of previous abdominal surgery: a systemic review and meta-analysis.","authors":"Liang Wang, Haichao Yan, Jiangtao Li","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Previous abdominal surgery (PAS) is an important factor for postoperative adhesion. It is considered to be the most common complication of gastrointestinal and pelvic surgery. Both an Internet based and a manual search were used to acquire relevant studies about this topic. Parameters have been compared such as, Operating time in PAS versus Non PAS, Blood loss, Perioperative blood transfusion, Conversion to open, Anastomotic leakage and overall complications. Results of this study suggest that laparoscopy is too safe and effective in the treatment of colorectal disease for patients with previous abdominal surgery as it is for those without surgical backgrounds. However sufficient large-volume study is necessary to validate the long-term outcomes in previous abdominal surgical patients.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 138","pages":"273-8"},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33253468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hepato-gastroenterology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1